Sun Pharmaceutical Faces Decline Amid Increased Trading Activity and Investor Hesitance
Sun Pharmaceutical Industries Ltd has experienced significant trading activity today, with a total volume of over 2.2 million shares. The stock's last traded price reflects a decline, reversing a previous four-day gain streak. It is currently trading near its 52-week low, indicating a challenging trading environment.
Sun Pharmaceutical Industries Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen significant trading activity today. The stock, trading under the symbol SUNPHARMA, recorded a total traded volume of 2,249,899 shares, with a total traded value of approximately Rs 36.40 crores. As of the latest update, the stock's last traded price (LTP) stands at Rs 1,611.1, reflecting a decline of 2.78% for the day. This marks a reversal from a previous four-day streak of gains, as the stock touched an intraday low of Rs 1,610, down 2.82% from the previous close of Rs 1,656.7. Notably, the stock is currently trading close to its 52-week low, just 3.88% above Rs 1,553.05.
In terms of performance metrics, Sun Pharmaceutical has underperformed its sector by 1.06% today. The stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, investor participation appears to be declining, with delivery volume dropping by 14.77% compared to the 5-day average.
Overall, Sun Pharmaceutical Industries Ltd is experiencing a challenging trading day, marked by notable declines and reduced investor activity.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
